Back To: Home

January 19-23, 2015
PepTalk - San Diego, CA

February 7-11, 2015
SLAS2015 - Washington, DC

More Events

NexMed closes acquisition of Bio-Quant
February 2010

EAST WINDSOR, N.J.NexMed Inc. announced in December the closing of its acquisition of Bio-Quant Inc., a privately held leading research organization for in vitro and in vivo contract drug discovery and preclinical development services. The agreement, announced in November, provides for NexMed's issuance of 4 million unregistered shares of its common stock to the Bio-Quant shareholders and a promissory note of approximately $12.1 million. Upon closing, Bio-Quant became a wholly owned subsidiary of NexMed. Dr. Bassam Damaj, co-founder and former CEO and chief scientific officer of Bio-Quant, was named president and CEO of NexMed, replacing Vivian Liu, who has assumed the role of executive vice president and was appointed chairman of the board of directors.


Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.